Evidence map›Paper›PMID 38396916›Full record

ArticleInternational journal of molecular sciences2024

Association of MDM2 Overexpression in Ameloblastomas with

Konstantinos I Tosios, Eleni-Marina Kalogirou, Ioannis G Koutlas

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Konstantinos I TosiosDepartment of Oral Pathology & Medicine and Hospital Dentistry, School of Dentistry, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-8834-6078
Eleni-Marina KalogirouFaculty of Health and Rehabilitation Sciences, Metropolitan College, 15125 Athens, Greece.ORCID 0000-0001-7891-4804
Ioannis G KoutlasDivision of Oral Pathology, School of Dentistry, University of Minnesota, Minneapolis, MN 55455, USA.
Metropolitan College · GRNational and Kapodistrian University of Athens · GRUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ameloblastoma is a rare tumor but represents the most common odontogenic neoplasm. It is localized in the jaws and, although it is a benign, slow-growing tumor, it has an aggressive local behavior and high recurrence rate. Therefore, alternative treatment options or complementary to surgery have been evaluated, with the most promising one among them being a targeted therapy with the

Indexed as

AmeloblastomaProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-mdm2AnimalsHumansIn Situ Hybridization, FluorescenceMiceMutationTumor Suppressor Protein p53BRAF protein, humanMDM2 protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53ameloblastomaBRAFfluorescencein situ hybridizationMDM2 proteinodontogenic tumorsp53

Identifiers

PMID38396916
PMCPMC10889355
OpenAlexW4391815274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.